Sitagliptin for the prevention of stress hyperglycemia in patients without diabetes undergoing coronary artery bypass graft (CABG) surgery

AIMS: To determine if treatment with sitagliptin, a dipeptidyl peptidase-4 inhibitor, can prevent stress hyperglycemia in patients without diabetes undergoing coronary artery bypass graft (CABG) surgery. METHODS: We conducted a pilot, double-blinded, placebo-controlled randomized trial in adults (18...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:BMJ Open Diabetes Res Care
Glavni autori: Cardona, Saumeth, Tsegka, Katerina, Pasquel, Francisco J, Fayfman, Maya, Peng, Limin, Jacobs, Sol, Vellanki, Priyathama, Halkos, Michael, Guyton, Robert A, Thourani, Vinod H, Galindo, Rodolfo J, Umpierrez, Guillermo
Format: Artigo
Jezik:Inglês
Izdano: BMJ Publishing Group 2019
Teme:
Cardiovascular and Metabolic Risk
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6731905/
https://ncbi.nlm.nih.gov/pubmed/31543976
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjdrc-2019-000703
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items